Study record · PEG-MGF
MGF-E peptide in primary human muscle progenitor cells
The study reported increased proliferation/fusion-related activity in some donor-age groups.
Key result
The study reported increased proliferation/fusion-related activity in some donor-age groups.
Study details
Study designIn-vitro human-cell study
PopulationPrimary human muscle progenitor cells
RouteIn vitro
Regimen / exposureNon-PEGylated MGF-E peptide
DurationCell-culture experiment
ComparatorControl cultures
Primary endpoint / questionProliferation and fusion potential
Safety resultNo human administration or clinical safety data.
Key limitationsThe tested peptide was MGF-E, not necessarily the commercial PEG-MGF product; in-vitro findings cannot establish muscle-building efficacy in humans.
Registry / identifierPMID 21354439